Sciences et Méthodes Séparatives, UNIROUEN , Normandie Université , 76000 Rouen , France.
Groupe de Physique des Matériaux, CNRS, INSA Rouen, UNIROUEN , Normandie Université , 76000 Rouen , France.
Mol Pharm. 2018 Mar 5;15(3):1112-1125. doi: 10.1021/acs.molpharmaceut.7b00993. Epub 2018 Jan 29.
The effect of low molecular weight excipients on drug-excipient interactions, molecular mobility, and propensity to recrystallization of an amorphous active pharmaceutical ingredient is investigated. Two structurally related excipients (α-pentaacetylglucose and β-pentaacetylglucose), five different drug:excipient ratios (1:5, 1:2, 1:1, 2:1, and 5:1, w/w), and three different solid state characterization tools (differential scanning calorimetry, X-ray powder diffraction, and dielectric relaxation spectroscopy) were selected for the present research. Our investigation has shown that the excipient concentration and its molecular structure reveal quasi-identical molecular dynamic behavior of solid dispersions above and below the glass transition temperature. Across to complementary quantum mechanical simulations, we point out a clear indication of a strong interaction between biclotymol and the acetylated saccharides. Moreover, the thermodynamic study on these amorphous solid dispersions highlighted a stabilizing effect of α-pentaacetylglucose regardless of its quantity while an excessive concentration of β-pentaacetylglucose revealed a poor crystallization inhibition. Finally, through long-term stability studies, we also showed the limiting excipient concentration needed to stabilize our amorphous API. Herewith, the developed procedure in this paper appears to be a promising tool for solid-state characterization of complex pharmaceutical formulations.
研究了低分子量赋形剂对药物-赋形剂相互作用、分子迁移率和无定形活性药物成分重结晶倾向的影响。选择了两种结构相关的赋形剂(α-五乙酰葡萄糖和β-五乙酰葡萄糖)、五种不同的药物:赋形剂比(1:5、1:2、1:1、2:1 和 5:1,w/w)和三种不同的固态特征化工具(差示扫描量热法、X 射线粉末衍射和介电弛豫光谱)用于本研究。我们的研究表明,赋形剂浓度及其分子结构在玻璃化转变温度以上和以下显示出固态分散体的准相同分子动力学行为。通过互补的量子力学模拟,我们指出了双氯曲美和乙酰化糖之间存在强烈相互作用的明确迹象。此外,对这些无定形固体分散体的热力学研究强调了 α-五乙酰葡萄糖的稳定作用,而无论其数量如何,过量的β-五乙酰葡萄糖都会导致较差的结晶抑制。最后,通过长期稳定性研究,我们还展示了稳定我们无定形 API 所需的限制赋形剂浓度。本文所开发的方法似乎是一种有前途的复杂药物制剂固态特征化工具。